Phase 3 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You had surgery to completely remove liver cancer (hepatocellular carcinoma), and the edge of tissue removed around the tumor was less than 1 cm wide, confirmed by lab results, surgical notes, and scans
- Your surgery took place within the last 4 months
- You have at least one additional factor that raises the risk of the cancer coming back — such as cancer found in small blood vessels near the tumor, a blood clot caused by the tumor, small satellite tumors nearby, a blood protein called AFP being above 400 ng/mL before surgery, or a tumor larger than 5 cm without a complete outer layer
- You are between 18 and 80 years old
- You are generally active and able to carry out daily activities with little to no limitation (confirm with trial site)
- Your liver is functioning at an acceptable level, based on a standard liver scoring system (confirm with trial site)
- You have had a special liver MRI scan after surgery to confirm no cancer remains in the liver
- If you have hepatitis B or C, your liver enzyme levels must be within a certain range and you must be receiving antiviral treatment
- Your liver enzyme levels (from a blood test) are within the ranges required by the trial
- You have no serious heart problems or abnormal heart rhythm readings on an ECG
- Your kidney function levels from blood tests are within an acceptable range
- Your blood counts (red blood cells, white blood cells, and platelets) meet the minimum levels required
- You are willing and able to give written consent to take part
Who may not be able to join:
- You had a significant tumor blood clot in the main portal vein or the large vein leading to the heart, seen on scans before surgery
- You have previously received treatments for liver cancer such as targeted therapy drugs, immunotherapy (e.g. PD-1 or PD-L1 inhibitors), or chemotherapy
- Your cancer had already spread to other parts of the body before joining the trial
- You have moderate to severe fluid build-up in your abdomen that does not respond to treatment
- You have a history of another type of cancer, unless it was a very early-stage or non-invasive cancer such as early thyroid cancer or a type of skin cancer (confirm with trial site)
- You have previously had radiotherapy to your abdomen
- You have serious problems with your heart, kidneys, or other major organs
- You have an active autoimmune disease or a significant mental health condition
- You are living with HIV
- You are pregnant or currently breastfeeding
- You are already taking part in another clinical trial that involves a treatment intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shuhang Wang, NCC, CICAMS
Phone: 8610-87788245
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-year RFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.